4-AMINO-2-UREIDO-PYRIMIDINE-5-CARBOXYLIC ACID ANILIDES AND THEIR USE IN TREATING LIPOMETABOLISM DISTURBANCES AND ADIPOSITY

摘要

What is disclosed are 4-amino-2-ureido (or -thioureido)-pyrimidine-5-carboxylic acid anilides of the formula further defined in the specification, and physiologically acceptable acid addition salts thereof, methods for treating adiposity and disturbances of the lipometabolism with these compounds or salts, and pharmaceutical compositions containing these compounds or salts and useful for inducing anorexia or affecting the lipometabolism.